AI Assistant
Blog
Pricing
Log In
Sign Up
Bcl-xL
as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in
BRAF
-mutant stage II and III colon cancer
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.